###begin article-title 0
Association and Mutation Analyses of 16p11.2 Autism Candidate Genes
###end article-title 0
###begin p 1
Conceived and designed the experiments: RAK CRM WBD SWS SLC. Performed the experiments: RAK TDB ZM KAA JS GG. Analyzed the data: RAK CRM JAB TDB ZM KAA JS CWB GG SK JS EC DHG. Wrote the paper: RAK SLC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Autism is a complex childhood neurodevelopmental disorder with a strong genetic basis. Microdeletion or duplication of a approximately500-700-kb genomic rearrangement on 16p11.2 that contains 24 genes represents the second most frequent chromosomal disorder associated with autism. The role of common and rare 16p11.2 sequence variants in autism etiology is unknown.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 778 784 778 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 834 840 834 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sez6l2</italic>
###xml 914 920 914 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 1059 1065 1059 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 855 860 <span type="species:ncbi:10090">mouse</span>
###xml 935 940 <span type="species:ncbi:9606">human</span>
To identify common 16p11.2 variants with a potential role in autism, we performed association studies using existing data generated from three microarray platforms: Affymetrix 5.0 (777 families), Illumina 550 K (943 families), and Affymetrix 500 K (60 families). No common variants were identified that were significantly associated with autism. To look for rare variants, we performed resequencing of coding and promoter regions for eight candidate genes selected based on their known expression patterns and functions. In total, we identified 26 novel variants in autism: 13 exonic (nine non-synonymous, three synonymous, and one untranslated region) and 13 promoter variants. We found a significant association between autism and a coding variant in the seizure-related gene SEZ6L2 (12/1106 autism vs. 3/1161 controls; p = 0.018). Sez6l2 expression in mouse embryos was restricted to the spinal cord and brain. SEZ6L2 expression in human fetal brain was highest in post-mitotic cortical layers, hippocampus, amygdala, and thalamus. Association analysis of SEZ6L2 in an independent sample set failed to replicate our initial findings.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
We have identified sequence variation in at least one candidate gene in 16p11.2 that may represent a novel genetic risk factor for autism. However, further studies are required to substantiate these preliminary findings.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 325 328 313 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Fombonne1">[1]</xref>
###xml 357 360 345 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Lecavalier1">[2]</xref>
###xml 394 397 370 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Levisohn1">[3]</xref>
###xml 566 569 542 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Courchesne1">[4]</xref>
###xml 571 574 547 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Geschwind1">[5]</xref>
###xml 825 828 801 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Zafeiriou1">[6]</xref>
###xml 1014 1017 978 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Kuehn1">[7]</xref>
###xml 1019 1022 983 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-YearginAllsopp1">[8]</xref>
###xml 1097 1100 1061 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Bailey1">[9]</xref>
###xml 1102 1106 1066 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Steffenburg1">[10]</xref>
Autism (MIM 209850) is a phenotypically and etiologically heterogeneous disorder of childhood characterized by impairments in social interaction, deficits in verbal and non-verbal communication, and restricted interests and repetitive behaviors. Co-morbid features include mental retardation (occurrence approximately30-60%) [1], anxiety and mood disorders [2], and seizures (approximately20%) [3]. Pathological and imaging studies indicate that structural brain abnormalities and aberrant synaptic connectivity may underlie the autism phenotype in some individuals [4], [5]. Autism comprises the severe end of a group of autism spectrum disorders (ASD), which also include Asperger syndrome, pervasive developmental disorder not otherwise specified (PDD-NOS), and rare syndromic forms including Fragile X and Rett syndromes [6]. Prevalence rates for autism and ASD are estimated at 0.2% and 0.6%, respectively, and males are more likely than females to have a diagnosis of ASD (male:female ratioapproximately4:1) [7], [8]. Twin and family-based studies indicate a strong genetic basis for autism [9], [10].
###end p 9
###begin p 10
###xml 126 130 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Vorstman1">[11]</xref>
###xml 132 136 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Xu1">[12]</xref>
###xml 248 252 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-VeenstraVanderweele1">[13]</xref>
###xml 351 355 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Vorstman1">[11]</xref>
###xml 357 361 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Martin1">[14]</xref>
###xml 647 651 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-AutismGenomeProjectConsortiumandSzatmari1">[15]</xref>
###xml 652 656 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Sebat1">[19]</xref>
###xml 788 792 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Marshall1">[18]</xref>
###xml 794 798 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Kumar1">[20]</xref>
###xml 800 804 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Weiss1">[21]</xref>
###xml 1067 1071 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Marshall1">[18]</xref>
###xml 1073 1077 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Kumar1">[20]</xref>
###xml 1079 1083 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Weiss1">[21]</xref>
###xml 1208 1212 1148 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Walsh1">[22]</xref>
###xml 1277 1281 1205 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Weiss1">[21]</xref>
###xml 779 787 <span type="species:ncbi:9606">patients</span>
###xml 969 977 <span type="species:ncbi:9606">patients</span>
###xml 1164 1172 <span type="species:ncbi:9606">patients</span>
###xml 1246 1254 <span type="species:ncbi:9606">patients</span>
The frequency of microscopically visible structural chromosomal imbalances in autism is high and estimated at approximately7% [11], [12]. The most frequent abnormality is maternal duplication 15q11-13, which account for approximately1-3% of autism [13]. Other commonly observed cytogenetic abnormalities include deletions of 2q37, 22q11.2 and 22q13.3 [11], [14]. Recently, submicroscopic copy number variants (CNVs) not otherwise detectable using traditional cytogenetic techniques have been identified using whole-genome microarray-based approaches such as array comparative genomic hybridization (aCGH) and high-density SNP genotyping platforms [15]-[19]. Among these newly identified CNVs are microdeletions of 16p11.2, which have been observed in approximately0.5% of autism patients [18], [20], [21] making this the second most common chromosomal abnormality in autism. The reciprocal 16p11.2 microduplication has also been observed in approximately0.5% of autism patients, although the association is less convincing given a higher frequency in control cohorts [18], [20], [21]. Interestingly, the duplication has recently been found in approximately2.4% of patients with childhood-onset schizophrenia [22] as well as in approximately0.07% patients with bipolar disorder [21].
###end p 10
###begin p 11
###xml 150 154 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Kumar1">[20]</xref>
###xml 525 533 <span type="species:ncbi:9606">patients</span>
The 16p11.2 microdeletion/duplication spans approximately500 kb and is flanked by approximately147-kb low copy repeats (LCRs) that are >99% identical [20]. The intervening single copy sequence contains approximately24 genes and the flanking 147-kb LCRs contain at least three genes. Genomic losses (and possibly gains) at 16p11.2 could directly contribute to the autism phenotype by affecting dosage-sensitive genes in this region, disrupting genes at the breakpoints or unmasking recessive mutations on the other allele. In patients without these imbalances, functional sequence variants in one or more genes in 16p11.2 may represent risk factors for autism.
###end p 11
###begin p 12
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Bodmer1">[23]</xref>
###xml 576 580 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Bodmer1">[23]</xref>
###xml 100 105 <span type="species:ncbi:9606">human</span>
Two hypotheses have been proposed for the contribution of functional variants to common and complex human diseases such as autism [23]. The common disease common variant (CDCV) hypothesis postulates that common variants with small to modest effects (allele frequencies >1%) may underlie susceptibility to common disorders. Alternatively, the common disease rare variant hypothesis (CDRV) suggests that susceptibility to common disorders may be due to low frequency (approximately0.01% to approximately1%) variants with moderate to high penetrance located in one or more genes [23]. The role of common and rare 16p11.2 sequence variants in the complex etiology of autism has not been examined. We therefore undertook a study of the 16p11.2 region to investigate the role of genetic variation in eight candidate genes we hypothesize may represent risk loci for autism spectrum disorders.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
Common genetic variation in 16p11.2
###end title 14
###begin p 15
###xml 426 430 426 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Weiss1">[21]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Marshall1">[18]</xref>
To assess whether common genetic variation at 16p11.2 might be associated with autism, we performed a family-based association analysis on two autism data sets that have recently been generated using two whole-genome high-density single nucleotide polymorphism (SNP) genotyping platforms. These microarray studies were performed on 777 families from the Autism Genetics Resource Exchange (AGRE) using the Affymetrix 5.0 array [21] and on 943 AGRE families using the Illumina Hap550 microarray () (Bucan and Hakonarson, unpublished). In addition, we analyzed data on 60 families generated from the Affymetrix 500 K platform [18].
###end p 15
###begin p 16
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Spielman1">[24]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Spielman2">[25]</xref>
###xml 362 370 362 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s001">Table S1</xref>
###xml 886 890 862 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">QPRT</italic>
We performed two types of tests: a transmission disequilibrium test (TDT) [24] with both parents genotyped and the DFAM test [25] using all families. The TDT identified one nominally significant association (p = 0.049) with intragenic marker rs7193756 (chr16:29,657,155-29,657,655) from the Affymetrix 5.0 data; however, the DFAM was not significant (p = 0.20) (Table S1). The association with rs7193756 and autism did not remain significant after correcting for multiple comparisons (region-wide p = 0.3576). The closest annotated gene to this marker is the transmembrane protein C16orf54 located approximately4-kb downstream of rs7193756. We used HapMap data () to generate linkage disequilibrium (LD) structure around rs719376, which indicated that it resides in an approximately56-kb block defined by markers rs9922666 and rs7205278 (chr16:29,605,876- 29,662,434) that contains the QPRT gene (data not shown).
###end p 16
###begin title 17
Rare genetic variation in candidate 16p11.2 genes
###end title 17
###begin p 18
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALDOA</italic>
###xml 317 322 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOC2A</italic>
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIRIP3</italic>
###xml 360 365 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPK3</italic>
###xml 381 384 381 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAZ</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP4C</italic>
###xml 421 427 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 447 452 447 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAOK2</italic>
###xml 468 476 468 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s002">Table S2</xref>
###xml 1073 1077 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Kumar1">[20]</xref>
###xml 1294 1301 1258 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004582-t001">Table 1</xref>
###xml 1466 1474 1430 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s003">Table S3</xref>
###xml 1553 1561 1517 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s004">Table S4</xref>
###xml 261 266 <span type="species:ncbi:10090">mouse</span>
###xml 1036 1044 <span type="species:ncbi:9606">patients</span>
###xml 1376 1384 <span type="species:ncbi:9606">patients</span>
We next addressed whether rare variants in 16p11.2 genes represent risk factors for autism. We performed a literature review of the 24 genes at 16p11.2 and selected the following eight candidate genes for mutation analysis based on biological function, genetic mouse models, and expression data: ALDOA (NM_000034.2), DOC2A (NM_003586.2), HIRIP3 (NM_003609.2), MAPK3 (NM_002746.2), MAZ (NM_002383.2), PPP4C (NM_002720.1), SEZ6L2 (NM_201575.2), and TAOK2 (NM_004783.2) (Table S2). For each of the eight candidate genes, we sequenced the coding regions and their associated splice sites, 5' and 3' untranslated regions (UTRs), and proximal promoter region (approximately1500 bp upstream of the transcription start site) in an initial minimum sample of approximately100 unrelated autism subjects. In parallel, we sequenced all eight candidate genes in approximately100 control subjects to assess the natural genetic variation at these loci and to identify autism-specific variants. We also sequenced these genes in five previously reported patients with 16p11.2 microdeletions [20] to test the hypothesis that microdeletions might unmask recessive alleles on the non-deleted chromosome. In total, we identified 26 novel, autism-specific rare variants, including 13 exonic and 13 promoter variants (Table 1). A complete description of these variants, including demographic data on patients, and conservation, transmission and segregation of each variant, is presented in Table S3. We also identified 44 control-specific variants in the eight genes examined (Table S4).
###end p 18
###begin title 19
Summary of exonic and promoter variants identified in autism.
###end title 19
###begin p 20
UTR, untranslated region; Pro, promoter (specific nucleotide position is specified in Table).
###end p 20
###begin p 21
Positions based on the following accession numbers: DOC2A (Q14183); HIRIP3 (Q9BW71); MAPK3 (P27361); SEZ6L2 (Q6UXD5); TAOK2 (Q9UL54).
###end p 21
###begin p 22
Positions based on the following accession numbers: ALDO, DOC2A, HIRIP3, and PPP4C (AC093512.2); MAZ (AC009133); MAPK3 (AC012645.7); SEZ6L2 (AC120114.2); TAOK2 (AC093512.2).
###end p 22
###begin p 23
Het, heterozygous; Hom, homozygous; Hemi, hemizygous.
###end p 23
###begin p 24
###xml 5 12 <span type="species:ncbi:9606">patient</span>
This patient harbors a 16p11.2 microdeletion.
###end p 24
###begin p 25
###xml 33 38 <span type="species:ncbi:9606">Human</span>
Based on UCSC Genome Browser (), Human March 2006 Assembly.
###end p 25
###begin p 26
Based on PolyPhen ().
###end p 26
###begin p 27
Number of individuals.
###end p 27
###begin title 28
Genetic variation in SEZ6L2 is associated with autism
###end title 28
###begin p 29
###xml 141 147 141 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Bork1">[26]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Bork2">[27]</xref>
###xml 1079 1085 1079 1085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
Our most interesting preliminary finding was a recurrent autism-specific R386H amino acid substitution in exon 7 of the seizure-related gene SEZ6L2 that we identified in our initial mutation screen (4/93 autism and 0/93 controls). This association was not significant with these low numbers but suggested a trend (Fisher's exact two tailed p = 0.12). We determined inheritance and segregation of R386H and demonstrated perfect segregation of this variant with the autism phenotype in all four families. This variant was not predicted to affect protein function using PolyPhen; however, R386H results in a strongly basic (arginine) to weakly basic (histidine) substitution in the CUB domain that is found almost exclusively in extracellular and plasma membrane-associated proteins, many of which are developmentally regulated [26], [27]. The R386 residue was conserved in 16 representative mammalian species and was present as H386 in five representative fish species (; hg18). The overall initial pattern of association and specificity to autism as well as the potential role of SEZ6L2 in seizures (which are present in approximately20% of autism cases) warranted further analyses of this gene.
###end p 29
###begin p 30
###xml 193 201 193 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s005">Table S5</xref>
###xml 545 553 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s006">Table S6</xref>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
We undertook a case-control association analysis of R386H by sequencing exon 7 in an additional 1013 autism patients and 1068 controls. The majority of these subjects were of European descent (Table S5). Among all individuals studied, we found a statistically significant association between R386H and autism (12/1106 autism versus 3/1161 controls; Fisher's exact two tailed p = 0.018). All 15 subjects harboring R386H were of European descent. In all cases, the variant was inherited with no bias between maternal versus paternal transmission (Table S6).
###end p 30
###begin p 31
###xml 37 45 <span type="species:ncbi:9606">patients</span>
We performed a phenotype analysis on patients with R386H. None of the probands or any of their affected siblings were reported to have seizures. No common phenotypic features were observed among subjects with R386H.
###end p 31
###begin p 32
We performed a replication study of R386H in independent autism and control cohorts, which failed to replicate our initial findings (4/529 autism versus 9/570 control; Fishers exact two tailed p = 0.42). Unexpectedly, five of the nine controls carrying the R386H variant had ancestry in the Orkney Islands, suggesting a possible founder effect. When all families with ancestry from the Orkneys were excluded from the control cohort, the findings were still not replicated.
###end p 32
###begin p 33
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 261 268 261 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004582-t001">Table 1</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Kumar1">[20]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Weiss1">[21]</xref>
###xml 642 648 642 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 775 779 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Duan1">[28]</xref>
###xml 112 120 <span type="species:ncbi:9606">patients</span>
###xml 489 496 <span type="species:ncbi:9606">patient</span>
To look for additional rare variants in SEZ6L2, we sequenced the remaining 16 exons in an additional 434 autism patients and 185 controls and identified seven autism-specific coding variants (four non-synonymous and three synonymous) and two promoter variants (Table 1). Examination of the autism-specific variants in parents and affected and/or unaffected siblings demonstrated that all variants were inherited. We identified a synonymous substitution in the middle of exon 2 (E38E) in a patient (HI2997) previously reported to harbor a 16p11.2 microdeletion [20], [21]. We cannot exclude the possibility that this substitution might affect SEZ6L2 regulation, as synonymous mutations can occasionally affect protein function by altering mRNA stability and protein synthesis [28].
###end p 33
###begin title 34
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 10 15 <span type="species:ncbi:9606">human</span>
Mouse and human expression studies of SEZ6L2
###end title 34
###begin p 35
###xml 13 20 13 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 149 155 149 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sez6l2</italic>
###xml 212 223 212 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004582-g001">Figure 1A&#8211;B</xref>
###xml 300 306 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sez6l2</italic>
###xml 539 545 539 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 682 693 682 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004582-g001">Figure 1C&#8211;K</xref>
###xml 736 742 736 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 838 842 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Amaral1">[29]</xref>
###xml 892 898 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
###xml 254 259 <span type="species:ncbi:10090">mouse</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 755 761 <span type="species:ncbi:9606">humans</span>
We performed in situ hybridization studies of SEZ6L2 in mouse embryos and human fetal brains. In mouse embryonic day 10.5 (e10.5) and e12.5 embryos, Sez6l2 expression was restricted to the brain and spinal cord (Figure 1A-B). We also reviewed the GENSAT mouse brain expression database (). At e15.5, Sez6l2 expression was highest in the olfactory bulb, cerebellum, and brainstem; at postnatal day 7, expression was widely distributed throughout the brain at low levels. Analyses of human fetal brains (gestational weeks 16-19) showed high SEZ6L2 expression in post-mitotic cortical layers, hippocampus, basal ganglia, amygdala, thalamus and at lower levels in the pons and putamen (Figure 1C-K). The developmental expression pattern of SEZ6L2 in mice and humans is consistent with the neurodevelopmental basis of autism spectrum disorder [29], thereby providing further support for a role of SEZ6L2 in autism.
###end p 35
###begin title 36
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 33 38 <span type="species:ncbi:9606">human</span>
SEZ6L2 is expressed in mouse and human central nervous systems.
###end title 36
###begin p 37
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 57 63 57 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sez6l2</italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 362 368 362 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
###xml 150 155 <span type="species:ncbi:9606">Human</span>
###xml 222 227 <span type="species:ncbi:9606">human</span>
In situ analyses in whole mouse embryos demonstrate that Sez6l2 mRNA is expressed in the developing brain and spinal cord at e10.5 (A) and e12.5 (B). Human SEZ6L2 transcript distribution was assayed in 18- and 19-week-old human brains sectioned in either coronal orientation in subjects 1137 (C), 1110 (D, E) and in the sagittal orientation in subject 4889 (F). SEZ6L2 is enriched in the cortical plate in the post mitotic neuron, in the ventricular zone, in the hippocampus, thalamus, ganglionic eminence, basal ganglia, and amygdala and at lower levels in the pons and the putamen. Emulsion picture of the dentate gyrus showing cellular specificity within the hippocampus (K). Sense controls tested on adjacent sections (not shown) gave no signal. Am, Amygdala; BG, Basal ganglia; CP, Cortical plate; DG, Dentate gyrus; GE, Ganglionic eminence; Hi, Hippocampus; Pu, Putamen; Th, Thalamus.
###end p 37
###begin title 38
Genetic variation in other 16p11.2 genes
###end title 38
###begin p 39
###xml 101 108 101 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004582-t001">Table 1</xref>
###xml 144 152 144 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s004">Table S4</xref>
###xml 369 374 369 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOC2A</italic>
###xml 607 614 <span type="species:ncbi:9606">patient</span>
We identified 16 autism-specific rare variants in seven additional 16p11.2 candidate genes analyzed (Table 1) and 33 control-specific variants (Table S4). Of the autism-specific variants, five were coding (all non-synonymous), one was located in the 5' UTR, and ten were promoter variants. One of the coding variants, M225I, was identified in the synaptic vesicle gene DOC2A and was predicted to alter protein function. This paternally inherited variant was also present in an affected sibling but absent in an unaffected sibling. In addition, M225I was absent in 258 control subjects. The ethnicity of the patient harboring M225I was indicated as 'White - Hispanic or Latino' and most of our controls are of European descent with no specific information on Hispanic or Latino ancestry. Therefore, M225I might represent a Hispanic/Latino-specific variant.
###end p 39
###begin p 40
###xml 216 224 216 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s003">Table S3</xref>
###xml 229 237 229 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s007">Table S7</xref>
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOC2A</italic>
For the promoter variants, we determined nucleotide conservation across several species, performed transcription factor binding site (TFBS) analyses, and determined transmission and segregation patterns in families (Table S3 and Table S7). One substitution of interest was a g.77883G>A change found in the DOC2A promoter region. This variant was predicted to alter binding sites for several transcription factors that have established roles in brain and behavioral development.
###end p 40
###begin p 41
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
We formally assessed the mutation burden of rare variants in patients versus controls, but did not detect a statistically significant difference in the total number of autism-specific variants compared to control-specific variants (Fisher's exact two tailed p = 0.42). We stratified our analyses by gene as well as by coding and promoter regions, and did not detect any significant differences in variant frequencies between patients and controls.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Reich1">[30]</xref>
###xml 782 790 782 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C16orf54</italic>
###xml 843 847 843 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">QPRT</italic>
We undertook a study of the 16p11.2 microdeletion/duplication region to investigate the role of common and rare genetic variation in 16p11.2 loci and risk for autism. Common and complex diseases such as autism can be due to genetic variation associated with a wide spectrum of allele frequencies [30]. We hypothesized that common and/or rare functional variants in one or more genes in 16p11.2 may confer susceptibility to autism. To elucidate the potential role of 16p11.2 common genetic variation in autism, we analyzed existing SNP genotyping data from the following platforms: Affymetrix 5.0, Illumina 550 K, and Affymetrix 500 K microarrays. Our analysis identified a single nominal association with rs7193756 that resides in a LD block that contains the transmembrane protein C16orf54 and the quinolinate phosphoribosyl-transferase gene QPRT. Overall, our association analyses indicate that common variation at 16p11.2 is not a major risk factor in autism. However, we cannot rule out the possibility that common (functional) variants not represented on the three commercially available microarrays may be associated with autism.
###end p 43
###begin p 44
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLGN3</italic>
###xml 372 377 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NLGN4</italic>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Jamain1">[31]</xref>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRXN1</italic>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-AutismGenomeProjectConsortiumandSzatmari1">[15]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Feng1">[32]</xref>
###xml 422 428 422 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SHANK3</italic>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Durand1">[33]</xref>
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Wilson1">[35]</xref>
###xml 453 460 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CNTNAP2</italic>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Alarcon1">[36]</xref>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Bakkaloglu1">[38]</xref>
###xml 567 573 567 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 619 625 619 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 755 758 743 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Levisohn1">[3]</xref>
###xml 760 766 748 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 844 849 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sez-6</italic>
###xml 924 928 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-ShimizuNishikawa1">[39]</xref>
###xml 1168 1172 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Bork2">[27]</xref>
###xml 1216 1222 1204 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 1377 1381 1365 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Abrahams1">[40]</xref>
###xml 1400 1406 1388 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sez6l2</italic>
###xml 1466 1470 1454 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Miyazaki1">[41]</xref>
###xml 1508 1511 1496 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ</italic>
###xml 1595 1599 1583 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Miyazaki1">[41]</xref>
###xml 230 233 <span type="species:ncbi:12143?0.0219256434699714">CNV</span>
###xml 745 753 <span type="species:ncbi:9606">patients</span>
###xml 910 915 <span type="species:ncbi:10090">mouse</span>
###xml 1200 1205 <span type="species:ncbi:10090">mouse</span>
###xml 1210 1215 <span type="species:ncbi:9606">human</span>
###xml 1383 1387 <span type="species:ncbi:10090">Mice</span>
###xml 1481 1485 <span type="species:ncbi:10090">mice</span>
###xml 1711 1719 <span type="species:ncbi:9606">patients</span>
We also hypothesized that one or more genes residing within the 16p11.2 region harbor rare variants that increase risk for autism. In other studies, systematic mutation screening of genes initially identified through chromosomal, CNV, and/or resequencing analysis has led to the discovery of rare autism-associated variants/mutations in several genes, including NLGN3 and NLGN4 at Xp22.3 [31], NRXN1 at 2p16.3 [15], [32], SHANK3 at 22q13 [33]-[35], and CNTNAP2 at 7q35 [36]-[38]. In the present study, we identified an initial significant association between a novel SEZ6L2 coding variant R386H and autism (p = 0.014). SEZ6L2 is an intriguing candidate given the increased risk of clinical or subclinical epilepsy in autism (approximately20% of patients) [3]. SEZ6L2 is referred to as a seizure-related gene because a closely related ortholog, Sez-6, is upregulated in response to seizure-inducing reagents in mouse neurons [39]. The R386H substitution resides within a CUB domain that is found in functionally diverse developmental proteins such as Tolloid (involved in dorso-ventral patterning) and A5 (critical for targeting growing axons during nerve innervation) [27]. Our expression studies of mouse and human SEZ6L2 in the developing embryo demonstrated high CNS-specific levels of brain expression, as would be expected for a neurodevelopmental disorder such as autism [40]. Mice deleted for Sez6l2 do not show any obvious defects in development or behavior [41]. However, mice deleted for all three SEZ family members exhibit abnormal behavior that includes impaired motor coordination [41]. It is possible that R386H may be necessary but not sufficient to produce autism and related disorders in some patients. Although the data presented here are insufficient to implicate a clear role for R386H in autism, follow-up investigations such as additional replication studies and functional experiments are warranted to evaluate its importance in disease risk.
###end p 44
###begin p 45
###xml 386 390 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Groffen1">[42]</xref>
###xml 392 396 392 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Orita1">[43]</xref>
###xml 482 484 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Doc2a</italic>
###xml 689 693 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Sakaguchi1">[44]</xref>
###xml 716 721 716 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOC2A</italic>
###xml 504 508 <span type="species:ncbi:10090">Mice</span>
###xml 750 757 <span type="species:ncbi:9606">patient</span>
Our screen for rare variants in seven additional genes identified several nucleotide substitutions of potential interest. The M225I substitution, predicted to affect protein function, was identified in the brain-specific synaptic vesicle-associated protein DOC2A (Double C2-Like Domain-Containing Protein, Alpha) that is thought to serve as a calcium sensor in neurotransmitter release [42], [43]. The M225I substitution is located between the two C2 domains, which interact with Ca2+ and phospholipids. Mice deleted for Doc2a show alterations in synaptic transmission and long-term potentiation and exhibit learning and behavioral deficits that include an abnormal passive avoidance task [44]. We also identified a DOC2A promoter variant in another patient that is predicted to alter transcription factor binding sites for several brain-expressed genes.
###end p 45
###begin p 46
###xml 1013 1017 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Feng1">[32]</xref>
###xml 1019 1023 1007 1011 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Durand1">[33]</xref>
###xml 1004 1012 <span type="species:ncbi:9606">patients</span>
###xml 1087 1095 <span type="species:ncbi:9606">patients</span>
###xml 1165 1173 <span type="species:ncbi:9606">patients</span>
In conclusion, we report an initial analysis of common and rare genetic variation in the 16p11.2 microdeletion/duplication region that is associated with approximately1% of autism cases. The novel rare variants identified in this study represent an initial catalog of low frequency, putative functional risk factors in autism. We do not report compelling evidence for a role of either common or rare genetic variants in autism etiology. Our findings might be interpreted to suggest that deletion and/or duplication of multiple genes in the 16p11.2 interval is a more significant genetic risk factor for predisposition to autism, rather than molecular risk contributed by any one gene at this locus. Given that our choice of eight candidate genes was somewhat biased towards biological function, it is also possible that other genes or genomic features in the 16p11.2 region might contribute to autism. Although mutations associated with autism have been identified by screening as few as several hundred patients [32], [33], one limitation of our study is the relatively small number of patients screened for rare variants. Additional studies in a larger number of patients for the genes examined here are warranted. In addition, the application of next-generation sequencing strategies to screen all genes and regulatory elements within the microdeletion/duplication may reveal more significant abnormalities.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
Ethics Statement
###end title 48
###begin p 49
###xml 23 29 <span type="species:ncbi:9606">humans</span>
All research involving humans and animals have been approved by the Institutional Review Boards of The University of Chicago, The University of Toronto, and The University of California, Los Angeles. All families provided written informed consent for the collection of samples and subsequent analysis.
###end p 49
###begin title 50
Autism and Control Subjects
###end title 50
###begin p 51
###xml 167 175 167 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s005">Table S5</xref>
Genomic DNA from autism and control subjects were obtained from various sources as described below. Ethnic breakdown for all autism and control groups are provided in Table S5. We obtained autism samples from several DNA repositories including the Autism Genetics Resource Exchange (AGRE) (n = 793) and the National Institutes of Mental Health (NIMH) (n = 313). For the AGRE sample set, the Autism Diagnostic Interview-Revised (ADI-R), Autism Diagnostic Observation Schedule (ADOS), Raven and Handedness, Peabody and Vineland assessments were performed. Medical histories and physical neurological exams were also collected. Additional phenotypic data on the AGRE sample set are available on the AGRE website (). Genomic DNA from control subjects were obtained from the NIMH Genetics Initiative Control sample set (n = 1161); these subjects were screened for any Axis I mental health disorders and none had a diagnosis of autism.
###end p 51
###begin p 52
###xml 97 105 <span type="species:ncbi:9606">Children</span>
###xml 124 129 <span type="species:ncbi:9606">child</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
Genomic DNA was also obtained from several Canadian institutions including The Hospital for Sick Children in Toronto and in child diagnostic centers in Hamilton, Ontario, and in St. John's, Newfoundland (n = 529). For the Canadian autism cohort, all subjects met ADI-R and ADOS criteria conclusively or on a clinical best estimate. Most index patients (approximately75%) were screened for fragilexmutations and were karyotyped. Wherever possible, experiments were performed on blood-derived genomic DNA (80%); otherwise, DNA from cell lines was used. Control DNA was isolated from cell lines from the Ontario Population Genomics Platform (n = 570). Subjects living in Ontario, Canada were recruited by telephone from a list of randomly selected residential telephone numbers for Ontario and from population-based Tax Assessment Rolls of the Ontario Ministry of Finance. Health and Ancestry of these subjects is self reported in an extensive questionnaire.
###end p 52
###begin title 53
Association analyses
###end title 53
###begin p 54
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Weiss1">[21]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Marshall1">[18]</xref>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Purcell1">[45]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Spielman1">[24]</xref>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Spielman2">[25]</xref>
###xml 281 289 <span type="species:ncbi:9606">Children</span>
Association analyses were performed on existing data generated on the following three SNP genotyping platforms: 1) Affymetrix 5.0 data available on 777 AGRE families by the Autism Consortium [21]; 2) IlluminaHap550 data available on 943 AGRE families by the microarray facility at Children's Hospital of Philadelphia () (Bucan and Hakonarson, unpublished); and 3) Affymetrix 500 K platform data on 60 families [18]. PLINK v1.03 was used for the analysis [45]. Two different types of analyses were performed. First, we performed the transmission disequilibrium test (TDT) [24] with permutation for families with 2 genotyped parents and 1 or more affected offspring. The permutation procedure flips transmitted/untransmitted status constantly for all SNPs for a given family, thereby preserving the linkage disequilibrium and linkage information between markers and siblings. Second, we used DFAM for all individuals. DFAM within PLINK implements the sib-TDT [25] and also allows for unrelated individuals to be included (via a clustered-analysis using the Cochran-Mantel-Haesnzel) and can be used to combine discordant sibship data, parent-offspring trio data and unrelated case/control data in a single analysis. Region-wide significance for both tests was estimated using the mperm option in PLINK which uses permutation to correct for multiple testing of all the markers within the region while taking linkage disequilibrium into account.
###end p 54
###begin title 55
DNA amplification and sequencing
###end title 55
###begin p 56
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ALDOA</italic>
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DOC2A</italic>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIRIP3</italic>
###xml 122 127 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAPK3</italic>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MAZ</italic>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PPP4C</italic>
###xml 183 189 183 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAOK2</italic>
###xml 389 397 389 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004582.s008">Table S8</xref>
Genes (accession numbers) examined in this study include: ALDOA (NM_000034.2), DOC2A (NM_003586.2), HIRIP3 (NM_003609.2), MAPK3 (NM_002746.2), MAZ (NM_002383.2), PPP4C (NM_002720.1), SEZ6L2 (NM_201575.2), and TAOK2 (NM_004783.2). PCR-amplification primers were designed using Primer3 () with M13 Forward and Reverse Tails added to each primer to facilitate high-throughput DNA sequencing (Table S8). DNA was amplified in a reaction comprised of: 20 ng genomic DNA, 1x buffer I (1.5 mM MgCl2, Applied Biosystems, Foster City, CA), 1 mM dNTPs (Applied Biosystems), 0.4 microM primer (each of forward and reverse, IDT, Coralville, IA), and 0.25 units AmpliTaq Gold (Applied Biosystems) in a total volume of 10 microl. Thermocycling conditions were as follows: 94degreesC for 10 min; 35 cycles of 94degreesC for 30 sec, annealing temperature (53-60degreesC) for 30 sec, and 72degreesC for 30 sec; and final extension of 72degreesC for 10 min. Variations in reaction composition and cycling conditions were required for a small number of amplicons. PCR products were purified in a 10 ul reaction comprised of 6.6 units Exonuclease I and 0.66 units shrimp alkaline phosphatase that were incubated at 37degreesC for 30 min followed by 80degreesC for 15 minutes. Sequencing reactions were performed using Big Dye terminators on an ABI 3730XL 96-capillary automated 3730XL DNA sequencer (Applied Biosystems) at The University of Chicago DNA Sequencing and Genotyping Core Facility. Sequence data were imported as AB1 files into Mutation Surveyor v3.10 (SoftGenetics, State College, PA). Sequence contigs were assembled by aligning the AB1 files against GenBank reference sequence files that were obtained from the National Center for Biotechnology Information (NCBI) (). Reference sequences included the complete 5' untranslated region (UTR), coding sequence and associated splice-sites, intronic sequence, and complete 3' UTR. The imported GenBank files provide annotated features for each gene that include base count, intron/exon boundaries, amino acid sequence, and previously reported mutations and single nucleotide polymorphisms (SNPs) from the SNP database (dbSNP) (). To screen for putative mutations, the entire length of the sample trace was manually inspected for quality and variation from the reference trace. All detected variants were visually reviewed by two trained individuals and were confirmed using bi-directional sequencing.
###end p 56
###begin title 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Human and mouse SEZ6L2 expression studies
###end title 57
###begin p 58
###xml 6 13 6 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-Chizhikov1">[46]</xref>
###xml 147 153 147 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sez6l2</italic>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 304 308 304 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004582-AbuKhalil1">[47]</xref>
###xml 314 320 314 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SEZ6L2</italic>
###xml 498 506 498 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 553 555 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 189 194 <span type="species:ncbi:9606">Human</span>
###xml 484 489 <span type="species:ncbi:9606">human</span>
Mouse in situ hybridization experiments were performed as previously described [46] on wildtype CD-1 whole embryos using DIG-labeled RNA probe for Sez6l2 (IMAGE clone 6467632, Invitrogen). Human in situ hybridization experiments were performed on fresh frozen post-fixed tissues as previously described. [47]. The SEZ6L2-specific sequence (MHS1011-59266) was obtained from OpenBiosystem (Huntsville, AL), sequenced for verification, and checked for specificity with BLAST against the human genome. In vitro transcription was then performed to generate S35-labeled cRNA. Labeled cRNA was hybridized on 20 microm thick cryostat frozen tissue sections, sectioned into either coronal or sagittal plane and opposed to autoradiography films for two to five days. Slides were then coated with NTB2 autoradiography emulsion (Kodak, New Haven, CT), exposed for four weeks, and developed. Following staining with cresyl violet, emulsion dipped slides were cover-slipped and imaged using Nikon Eclipse E600 microscope with a Digital Capture System built around spot cooled CCD camera. Corresponding sense probes were used on sections adjacent to those used for antisense probes.
###end p 58
###begin title 59
Bioinformatic and statistical analyses
###end title 59
###begin p 60
Gene selection was performed using the UCSC Genome browser () and literature review of articles published in PubMed (). PolyPhen was used to predict whether amino acid substitutions affect protein function. The differences in frequency of any variant between cases and controls were assessed using the Fishers Exact test.
###end p 60
###begin title 61
Supporting Information
###end title 61
###begin p 62
Family-based association analyses of 16p11.2 markers in autism
###end p 62
###begin p 63
(0.08 MB XLS)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
Candidate 16p11.2 genes selected for mutation analyses
###end p 65
###begin p 66
(0.14 MB XLS)
###end p 66
###begin p 67
Click here for additional data file.
###end p 67
###begin p 68
Complete summary of exonic and promoter variants identified in autism
###end p 68
###begin p 69
(0.04 MB XLS)
###end p 69
###begin p 70
Click here for additional data file.
###end p 70
###begin p 71
Control specific variants identified in eight candidate 16p11.2 genes
###end p 71
###begin p 72
(0.04 MB XLS)
###end p 72
###begin p 73
Click here for additional data file.
###end p 73
###begin p 74
Ancestries of autism and controls subjects used in mutation screen and association analyses
###end p 74
###begin p 75
(0.03 MB DOC)
###end p 75
###begin p 76
Click here for additional data file.
###end p 76
###begin p 77
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Inheritance and segregation analysis in patients with R386H
###end p 77
###begin p 78
(0.02 MB XLS)
###end p 78
###begin p 79
Click here for additional data file.
###end p 79
###begin p 80
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Promoter variants identified in autism patients
###end p 80
###begin p 81
(0.05 MB XLS)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
PCR primers used to amplify candidate genes on 16p11.2
###end p 83
###begin p 84
(0.11 MB XLS)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 238 246 <span type="species:ncbi:9606">patients</span>
We thank Autism Speaks for awarding Postdoctoral Fellowships to Ravinesh A. Kumar and Camille W. Brune. We gratefully acknowledge the resources provided by the Autism Genetic Resource Exchange (AGRE) Consortium and the participating AGRE patients and families. Additional autism families and the control samples were acquired as part of the NIMH Center for Collaborative Genetic Studies on Mental Disorders. The authors are grateful to the following undergraduate students for their commitment to this study: Mayon Yen and Ismarc Reyes.
###end p 86
###begin title 87
References
###end title 87
###begin article-title 88
Past and future perspectives on autism epidemiology.
###end article-title 88
###begin article-title 89
###xml 43 49 <span type="species:ncbi:9606">people</span>
Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification.
###end article-title 89
###begin article-title 90
The autism-epilepsy connection.
###end article-title 90
###begin article-title 91
Mapping early brain development in autism.
###end article-title 91
###begin article-title 92
Autism spectrum disorders: developmental disconnection syndromes.
###end article-title 92
###begin article-title 93
Childhood autism and associated comorbidities.
###end article-title 93
###begin article-title 94
CDC: autism spectrum disorders common.
###end article-title 94
###begin article-title 95
Prevalence of autism in a US metropolitan area.
###end article-title 95
###begin article-title 96
Autism as a strongly genetic disorder: evidence from a British twin study.
###end article-title 96
###begin article-title 97
A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden.
###end article-title 97
###begin article-title 98
Identification of novel autism candidate regions through analysis of reported cytogenetic abnormalities associated with autism.
###end article-title 98
###begin article-title 99
Molecular Cytogenetics of Autism.
###end article-title 99
###begin article-title 100
Autism as a paradigmatic complex genetic disorder.
###end article-title 100
###begin article-title 101
Autism and cytogenetic abnormalities: solving autism one chromosome at a time.
###end article-title 101
###begin article-title 102
Mapping autism risk loci using genetic linkage and chromosomal rearrangements.
###end article-title 102
###begin article-title 103
Novel Submicroscopic Chromosomal Abnormalities Detected in Autism Spectrum Disorder.
###end article-title 103
###begin article-title 104
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders.
###end article-title 104
###begin article-title 105
Structural variation of chromosomes in autism spectrum disorder.
###end article-title 105
###begin article-title 106
Strong association of de novo copy number mutations with autism.
###end article-title 106
###begin article-title 107
Recurrent 16p11.2 microdeletions in autism.
###end article-title 107
###begin article-title 108
Association between microdeletion and microduplication at 16p11.2 and autism.
###end article-title 108
###begin article-title 109
Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia.
###end article-title 109
###begin article-title 110
Common and rare variants in multifactorial susceptibility to common diseases.
###end article-title 110
###begin article-title 111
Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM).
###end article-title 111
###begin article-title 112
A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test.
###end article-title 112
###begin article-title 113
###xml 62 76 <span type="species:ncbi:8355">Xenopus laevis</span>
Complement components C1r/C1s, bone morphogenic protein 1 and Xenopus laevis developmentally regulated protein UVS.2 share common repeats.
###end article-title 113
###begin article-title 114
The CUB domain. A widespread module in developmentally regulated proteins.
###end article-title 114
###begin article-title 115
###xml 28 33 <span type="species:ncbi:9606">human</span>
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor.
###end article-title 115
###begin article-title 116
Neuroanatomy of autism.
###end article-title 116
###begin article-title 117
###xml 27 32 <span type="species:ncbi:9606">human</span>
On the allelic spectrum of human disease.
###end article-title 117
###begin article-title 118
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.
###end article-title 118
###begin article-title 119
###xml 71 79 <span type="species:ncbi:9606">patients</span>
High frequency of neurexin 1beta signal peptide structural variants in patients with autism.
###end article-title 119
###begin article-title 120
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders.
###end article-title 120
###begin article-title 121
Contribution of SHANK3 mutations to autism spectrum disorder.
###end article-title 121
###begin article-title 122
Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.
###end article-title 122
###begin article-title 123
Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene.
###end article-title 123
###begin article-title 124
A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism.
###end article-title 124
###begin article-title 125
Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders.
###end article-title 125
###begin article-title 126
Cloning and characterization of seizure-related gene, SEZ-6.
###end article-title 126
###begin article-title 127
Advances in autism genetics: on the threshold of a new neurobiology.
###end article-title 127
###begin article-title 128
###xml 56 60 <span type="species:ncbi:10090">mice</span>
Disturbance of cerebellar synaptic maturation in mutant mice lacking BSRPs, a novel brain-specific receptor-like protein family.
###end article-title 128
###begin article-title 129
DOC2A and DOC2B are sensors for neuronal activity with unique calcium-dependent and kinetic properties.
###end article-title 129
###begin article-title 130
Doc2: a novel brain protein having two repeated C2-like domains.
###end article-title 130
###begin article-title 131
Doc2alpha is an activity-dependent modulator of excitatory synaptic transmission.
###end article-title 131
###begin article-title 132
PLINK: a tool set for whole-genome association and population-based linkage analyses.
###end article-title 132
###begin article-title 133
Control of roof plate development and signaling by Lmx1b in the caudal vertebrate CNS.
###end article-title 133
###begin article-title 134
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Wnt genes define distinct boundaries in the developing human brain: implications for human forebrain patterning.
###end article-title 134
###begin p 135
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 135
###begin p 136
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by grants to Susan L. Christian from the National Alliance for Autism Research and the National Institute of Neurological Diseases and Stroke (1R01 NS51812), as well as to Daniel H. Geschwind (PI) from the National Institute of Mental Health (MH64547), National Institute of Mental Health (MH081754) and the Method to Extend Research in Time (MERIT) from the National Institute of Mental Health (MH60233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 136

